DNMT3A and B-cell chronic lymphocytic leukemia: In a separate study, conditional deletion of Dnmt3a in stem/progenitor cells led to chronic lymphocytic leukemia (CLL) with a median survival of 371 days, which was accelerated by the combined deletion of Dnmt3b [86].